Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGLEC7 | Q9Y286 | 6/20 | 0.54 |
| ▸ | SELL | P14151 | 1/20 | 0.47 |
| ▸ | SELP | P16109 | 1/20 | 0.47 |
| ▸ | MAG | P20916 | 3/20 | 0.47 |
| ▸ | CD22 | P20273 | 8/20 | 0.43 |
| ▸ | SELE | P16581 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25588677 | 0.91 | SELL (0.54) | SIGLEC7SELLSELPMAGCD22 | |
| SCHEMBL17973944 | 0.91 | SELL (0.54) | SIGLEC7SELLSELPMAGCD22 | |
| SCHEMBL25588663 | 0.91 | SELL (0.54) | SIGLEC7SELLSELPMAGCD22 | |
| SCHEMBL17988419 | 0.91 | SELL (0.54) | SIGLEC7SELLSELPMAGCD22 | |
| SCHEMBL20248131 | 0.91 | SIGLEC7 (0.55) | SIGLEC7SELLSELPMAGCD22 | |
| SCHEMBL14683505 | 0.91 | SIGLEC7 (0.55) | SIGLEC7SELLSELPMAGCD22 | |
| SCHEMBL20252455 | 0.91 | SIGLEC7 (0.55) | SIGLEC7SELLSELPMAGCD22 | |
| SCHEMBL14683506 | 0.91 | SIGLEC7 (0.55) | SIGLEC7SELLSELPMAGCD22 | |
| SCHEMBL23219557 | 0.89 | SIGLEC7 (0.67) | SIGLEC7SELLSELPMAGCD22 | |
| SCHEMBL15959569 | 0.89 | SIGLEC7 (0.67) | SIGLEC7SELLSELPMAGCD22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160160163-A1 | PROCESS FOR PRODUCING NOVEL SIALO-SUGAR CHAIN | WAKAYAMA UNIVERSITY (JP) | 2016-06-09 | — | — | US | disclosed |
| US-9290532-B2 | Process for producing novel sialo-sugar chain | WAKAYAMA UNIVERSITY (JP) | 2016-03-22 | — | — | US | disclosed |
| US-20140235839-A1 | PROCESS FOR PRODUCING NOVEL SIALO-SUGAR CHAIN | WAKAYAMA UNIVERSITY (JP) | 2014-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140235839-A1 | PROCESS FOR PRODUCING NOVEL SIALO-SUGAR CHAIN | NEU1, NEU2, NEU4 | SIGLEC7 11/4885SELL 454/4885SELP 368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.